FindTrial
Sign In

Clinical Training Dosage of Robotic Exoskeleton Assisted Gait Training for Improvement of Gait Parameters, Walking Performance, Balance and Health-related Benefits in Patients with Chronic Stroke: a Randomized Controlled Trial

Clinical Training Dosage of Robotic Exoskeleton Assisted Gait Training for Improvement of Gait Parameters, Walking Performance, Balance and Health-related Benefits in Patients with Chronic Stroke: a Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061817
Enrollment
Unknown
Registered
2022-07-03
Start date
2022-06-20
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Control:Exoskeleton walking once a week
Experimental:Exoskeleton walking 5 times a week

Sponsors

Caritas Institute of Higher Education
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Participants will be recruited if they fulfill the following inclusion criteria: 1. Currently in the chronic phase of stroke (>= 6 months post stroke); 2. Able to walk with supervision; 3. Body weight equals to or is less than 100 kg; 4. There are no severe deformities, spasticity or restricted motion in the legs; 5. Able to follow verbal instructions.

Exclusion criteria

Exclusion criteria: Not cooperative or have unstable medical conditions or musculoskeletal diseases which affect mobility.

Design outcomes

Primary

MeasureTime frame
Gait parameters;Walking performance;Balance;—

Secondary

MeasureTime frame
Health-related benefits;—

Countries

China

Contacts

Public ContactChoi Ching Man

2 Chui Ling Lane, Tseung Kwan O, New Territories, Hong Kong

cmchoi@cihe.edu.hk+852 98125086

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026